Ticker
AEMD

Price
0.61
Stock movement down
-0.05 (-7.76%)
Company name
Aethlon Medical Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsverdi
13.97M
Ent verdi
-2.46M
Pris/omsetning
462.07
Pris/bok
0.70
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
-
Etterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års avkastning
-59.41%
3 års avkastning
-38.68%
5 års avkastning
-50.57%
10 års avkastning
-36.49%
Sist oppdatert: 2023-02-03

UTBYTTE

AEMD betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning462.07
Pris til bok0.70
EV i forhold til salg-81.22

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall22.95M
EPS (TTM)-0.63
FCF per aksje (TTM)-0.60

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)30.23K
Bruttofortjeneste (TTM)17.12K
Driftsinntekter (TTM)-12.89M
Netto inntekt (TTM)-13.03M
EPS (TTM)-0.63
EPS (1 år fremover)-0.71

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)56.62%
Driftsmargin (TTM)-42619.11%
Fortjenestemargin (TTM)-43085.77%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter19.60M
Netto fordringer114.85K
Samlede omløpsmidler20.50M
Goodwill0.00
Immaterielle eiendeler1.93K
Eiendom, anlegg og utstyr0.00
Sum eiendeler23.05M
Leverandørgjeld361.00K
Kortsiktig/nåværende langsiktig gjeld1.32M
Sum kortsiktig gjeld2.10M
Sum gjeld3.18M
Aksjonærenes egenkapital19.87M
Netto varige driftsmidler19.87M

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)-11.42M
Kapitalutgifter (TTM)1.05M
Fri kontantstrøm (TTM)-12.48M
Utbetalt utbytte (TTM)0.00

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-65.56%
Avkastning på eiendeler-56.52%
Avkastning på investert kapital-64.76%
Kontantavkastning på investert kapital-62.02%

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning0.66
Daglig høy0.69
Daglig lav0.59
Daglig volum630K
Tidenes høyeste6750.00
1 år analytikerestimat8.50
Beta0.89
EPS (TTM)-0.63
Utbytte per aksje-
Ex-div dato-
Neste dato for resultatpresentasjon13 Feb 2023

Nedsidepotensial

Loading...
Nedsidepotensial-data
AEMDS&P500
Nåværende prisfall fra toppnotering-99.99%-13.68%
Høyeste prisfall-100.00%-56.47%
Dato for høyeste fall28 Dec 20229 Mar 2009
Gj.snittlig fall fra topp-94.94%-11.49%
Gj.snittlig tid til ny topp195 days13 days
Maks tid til ny topp5238 days1805 days
SELSKAPSOPPLYSNINGER
AEMD (Aethlon Medical Inc) company logo
Markedsverdi
13.97M
Markedsverdi kategori
Small-cap
Beskrivelse
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Ansatte
14
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Timothy C. Rodell
Land
USA
By
San Diego
Aksjetype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the upcom...
31. januar 2023
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today announced that it has entered into an agreement with NAMSA...
30. januar 2023
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Studying the Hemopurifier in a range of cancers Aethlon Medical’s (NASDAQ:AEMD) provided a business update. AEMD has been working to launch a...
16. november 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial resul...
14. november 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its se...
2. november 2022
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor c...
12. september 2022
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that it will b...
6. september 2022
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Expanding the Potential Indications for Hemopurifier Treatment Aethlon Medical’s (NASDAQ:AEMD) clinical trials are moving forward and expandi...
17. august 2022
With the business potentially at an important milestone, we thought we'd take a closer look at Aethlon Medical, Inc.'s...
15. august 2022
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthca...
10. august 2022
Neste side